All News

By risk-stratifying nonmuscle-invasive bladder cancers, urologists can characterize pathologic subtypes and develop individualized treatment and surveillance strategies.(CME)

Many post-prostatectomy incontinence patients have concomitant sphincteric and bladder dysfunctions.

Dr. Tanagho, professor emeritus of urology at the University of California, San Francisco, discusses the history of neurostimulation in urology, its current applications, and possible future directions.

Adjuvant chemotherapy is an essential part of the treatment protocol for lymph node-positive bladder cancer.

Increasing the radiation dose for better local control of prostate cancer does not increase long-term toxicity.

Willie Underwood, III, MD, MSci, MPH, a member of AUA's Legislative Workgroup, was to help the CBC develop its recommendations to Congress for national health care reform.

Corpus Christi, TX-CSMG Technologies has received approval from FDA to market the LTC VAD system, a .400 bipolar electrosurgical generator and two disposable sealing instruments. The tissue binding/welding system is intended for use in open general surgical and gynecologic procedures for ligation of vessels and ducts as an alternative to mechanical clamping or suturing. This third-generation bipolar system can be used on vessels up to 7 mm in diameter, ducts up to 2 mm in diameter, and tissue bundles that fit within the jaws' electrodes.

This article shows you how to make the most of referral sources that often get little attention: friends, family, and community connections.

We review a sampling of software and hardware for the office-based practice that can improve the way you practice, increase your efficiency, and enhance your communication with patients.

Varicocele repair supports the hypothesis that this operation may help to restore fertility by reducing oxidant stress.

Being denied payment for PSA tests.

Physician attitudes, actions at odds over preserving fertility in adolescent men with cancer.

Risks of developing melanoma and prostate cancer are increased among those with a diagnosis of male factor infertility.

The prostate cancer biomarker TMPRSS2-ERG is superior to DNA-based assays.

Prostate cancer patients who received radiation therapy were almost twice as likely to develop a secondary malignancy.

Lymph node-positive prostate cancer is not always indicative of systemic disease.

Radical prostatectomy patients are most likely to use medication for erectile dysfunction after surgery; those who underwent laparoscopic/robotic prostatectomy were most likely to use ED drugs.

The 2008 update of the American Urological Association clinical guidelines for prostate-specific antigen screening will build on the 2000 version while addressing some controversial aspects of screening.

The 20-milligrams per day tamoxifen therapy reduced the severity of androgen deprivation therapy-related symptoms in prostate cancer patients.

Determining androgen receptor activity in castration-resistant prostate cancer may have potential for distinguishing patients who will respond to androgen deprivation from those who will not.

In men with nonmetastatic prostate cancer treated with intermittent androgen deprivation, thalidomide (Thalomid) significantly prolonged progression-free survival compared with placebo.

Intermittent androgen deprivation with a luteinizing hormone-releasing hormone analog causes fewer side effects and preserves quality of life compared with continuous combined androgen ablation, and many patients have prolonged treatment-free intervals.

Proper diagnosis and treatment of posterior urethral defects from pelvc fractures is critical toward preventing incontinence, impotence, and recurrent stricture disease.

This article describes a risk-stratified approach based on a three-zone anatomic layout to the periprostatic neural architecture and a modified athermal robotic technique for better continence and potency outcomes without compromising surgical margin rates.

The value and timing of chemotherapy in patients undergoing cystectomy for clinically localized bladder cancer has long been controversial. There are myriad reasons supporting both neoadjuvant and adjuvant chemotherapies.

Urologist Andrew C. Novick, MD, chairman of the Cleveland Clinic Glickman Urological and Kidney Institute, died Oct. 18 from complications of lymphoma. He was 60.

An algorithm based on near-infrared spectroscopy (NIRS) is able to correctly identify more than 85% of men classified as obstructed, using catheter urodynamics, according to study findings published in the Canadian Journal of Urology (2008; 1515:4241-8).

A profound gap exists in the understanding of physicians about the literacy levels of their patients related to the efficacy of written screening tools, including the International Prostate Symptom Score, researchers from Emory University School of Medicine, Atlanta, reported.